SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-264471
Filing Date
2019-10-08
Accepted
2019-10-08 16:16:06
Documents
4
Period of Report
2019-10-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d810930d8k.htm 8-K 22299
2 EX-99.1 d810930dex991.htm EX-99.1 23099
3 GRAPHIC g810930g1004190400476.jpg GRAPHIC 3968
4 GRAPHIC g810930g1004190400554.jpg GRAPHIC 5361
  Complete submission text file 0001193125-19-264471.txt   59762
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38137 | Film No.: 191142859
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences